CX-1739

N/A

Report date: 2024/05/30 14:53:51
NME

Base Information

Drug NameCX-1739
Drug Alias NameCX-1739CX1739
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate receptor ionotropic AMPA modulators
TargetsGlutamate receptor ionotropic AMPA
Therapy Area/IndicationsUrologic DiseasesUrinary Bladder, NeurogenicRespiratory Insufficiency +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesRespirerx Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesRespirerx Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsUrologic DiseasesUrinary Bladder, NeurogenicRespiratory Insufficiency +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A